Dr Reddy’s Laboratories Ltd, a global pharmaceutical company, announced that its tocilizumab biosimilar candidate, DRL_TC, successfully met its primary and secondary endpoints in a phase 1 study. This phase 1 study used a subcutaneous formulation...
Apollo Hospitals, a leading quaternary care hospital, has launched a dedicated free support group and helpline number to support those with colorectal cancer and a stoma clinic....
Clariant is set to expand its Care Chemicals facility in Daya Bay, Huizhou, China, to boost its support for pharmaceutical, personal care, home care, and industrial application customers...
Everest Medicines, a biopharmaceutical company, announced that the company has achieved the preclinical proof-of-concept milestone for its mRNA rabies vaccine programme. This new vaccine candidate for rabies post-exposure prophylactic was...
Hindustan Foods said that it has executed business transfer agreement (BTA) for acquisition of Reckitt Benckiser Health India's (Reckitt) manufacturing facility in Village Sandholi, Baddi, Himachal Pradesh, as a move to further expand its Health Care
PrecisionLife Limited, a global techbio company generating the deepest insights into disease biology to create novel precision medicines in chronic diseases, announced that it has entered into a multi-target discovery and validation partnership...
In this article, let's look into how the healthcare industry is transiting towards preventive care, and explore the key technologies that are enabling it.
To promote discovery of newer therapeutic agents and approaches in the area of inherited rare diseases, the Indian Council of Medical Research (ICMR) has called for proposals on “Therapeutics for inherited rare diseases†from scientists working in...
Takeda Biopharmaceuticals India Private Limited launched Cinryze an innovative injectable prescription medicine for the treatment of hereditary angioedema (HAE) patients. With eight years of global clinical experience proving efficacy and safety,...
The Center of Excellence in 3D bioprinting of Cellink at the Indian Institute of Science (IISc), Bengaluru is expected to advance regenerative medicine, tissue engineering and drug discovery. The operations of the facility have commenced after...
, CDSCO.jpg)
